跳至主要内容
临床试验/TCTR20190114001
TCTR20190114001尚未招募4 期

Effectiveness of extended dose of tranexamic acid for 48 hours vs single dose perioperative tranexamic acid on reduction of blood loss after primary total knee arthroplasty: A randomized controlled trial

Faculty of Medicine, Prince of Songkla university0 个研究点目标入组 94 人开始时间: 2019年1月14日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients undergoing primary unilateral total knee arthroplasty
  • Diagnosis of primary osteoarthritis of knee
  • Age less than 85 years old

排除标准

  • 1.Previous surgery around the affected knee
  • 2.Complex TKA requiring the use of stemmed prosthesis
  • 3.Use of anticoagulant at the time of admission
  • 4.Documented allergy to drug in the study
  • 5.History of deep vein thrombosis or pulmonary embolism
  • 6.Abnormal coagulation at admission
  • International normalized ration > 1.5
  • Partial thromboplastin time > 1.4x normal
  • Platelet < 50,000/microL
  • 7.Abnormal liver function test
  • Aspartate transaminase/Alanine transaminase > 3x normal
  • Alkaline phosphatase > 5x normal
  • 8.Calculated glomerular filtration rate < 30 mL/min
  • 9.History of acute coronary syndrome or cerebrovascular accident in the past 12 months
  • 10.Active cancer
  • 11.Use of drug with interaction with Tranexamic acid; eg. Tretinoin, Estrogen, Oral contraceptive pill

研究者

发起方
Faculty of Medicine&#44; Prince of Songkla university

相似试验